Related Experiment Video
Updated: Jul 8, 2026

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
Defining the defect in F508 del CFTR: a soluble problem?
Charles M Deber1, Joanne C Cheung, Arianna Rath
1Division of Molecular Structure & Function, Research Institute, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada. deder@sickkids.ca
Partial rescue of cystic fibrosis transmembrane conductance regulator (CFTR) trafficking and gating defects was observed in vivo. This rescue was achieved by introducing specific mutations alongside the F508del mutation in full-length CFTR.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Previously, crystal structures of CFTR F508del-NBD1 were determined using solubilizing mutations.
- The F508del mutation is the most common cause of cystic fibrosis, leading to protein misfolding and degradation.
Discussion:
- Pissarra et al. (2008) investigated the in vivo effects of specific mutations on full-length CFTR trafficking and gating.
- The study recapitulated solubilizing mutations (F494N/Q637R or F428S/F494N/Q637R) in cis with F508del.
Key Insights:
- Partial rescue of trafficking and gating defects of full-length CFTR was demonstrated in vivo.
- The combination of F508del with specific solubilizing mutations partially restored CFTR function.
Outlook:
- These findings could inform therapeutic strategies aimed at correcting CFTR protein defects.
- Further research may explore optimizing these rescue strategies for clinical application.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Imperfections in Crystal Structure: Stoichiometric Point Defects
Imperfections in Crystal Structure: Non-Stoichiometric Defects
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Export of Misfolded Proteins out of the ER

